Back to search

Article

Targeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC

2023-03-17

Abstract excerpt

The NFE2L2/NRF2 oncogene and transcription factor drives a gene expression program that promotes cancer progression, metabolic reprogramming, immune evasion and chemoradiation resistance. Patient stratification by NRF2 activity may guide treatment decisions to improve outcome. Here, we developed a mass spectrometry (MS)-based targeted proteomics assay based on internal standard triggered parallel reaction monitori...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
58c488f6-c7be-5d83-8d7a-67e25333bbd0
DOI
10.1101/2023.03.13.532474
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCCDOI 10.1101/2023.03.13.532474
Select a neighboring publication to make it the new centre.